The anxiety relief your doctor ordered is ready

Feel better without pharmacies, pills, or pickups.

Daylight® is a digital treatment proven to help people overcome anxiety — available to you for just $99.*1

Why Daylight?

Trusted by your doctor

Daylight is a clinically validated digital treatment that doctors like yours trust to be safe and effective.1

No pills, no hassles

Get relief without pharmacies or consults. Start Daylight today from the privacy of your phone.

With you for life

Daylight benefits are proven to last,2 because you learn techniques that will help you forever.

Get started in four easy steps

  • Receive your access code after making a $99 payment
  • Set up your Daylight account on the following page
  • Download the Sleepio app from the Apple App Store or Google Play
  • Log in to Sleepio and begin your journey to better sleep for life

Take the first step with confidence

You don’t have to wonder if Daylight works. It's already proven to be safe and effective.1


Recovered from anxiety.1


Experienced better overall mood.1


Got better sleep.1


What is Daylight?
Daylight is a digital treatment for anxiety. The program guides you step-by-step through techniques based in cognitive behavioral therapy (CBT) that are proven to help people experience less anxiety over time
How much does Daylight cost?
Daylight is available to HCA Healthcare members for $99 (this program typically costs $400-600). Credit cards and FSA/HSA funds can be used to purchase Daylight. If you run into any issues, please email our Customer Support team at for assistance – we’re happy to help.
What is cognitive behavioral therapy (CBT) and how does it work?
Cognitive behavioral therapy (CBT) is a treatment for breaking the vicious cycle of negative thoughts, feelings, and behaviors that maintain symptoms, and is recommended for a range of issues. Daylight’s CBT techniques are clinically effective in providing long-term relief from worry and anxiety.
Does Daylight work?
Yes! In a clinical trial, 71% of Daylight users in the study achieved remission of generalized anxiety disorder (GAD), as compared to 33% of those in the control group.
How long will it take to see results?
In our research, we have seen that members who use Daylight frequently (approximately daily) can start to notice benefits in as little as 3-4 weeks, and that using the app frequently for up to 6 weeks can lead to even better results.
How are my privacy and data handled?
We have policies and procedures in place to protect your data from improper use and disclosure. The information you provide is encrypted and stored on secure servers. For more details, refer to our Privacy Policy.
How do I access Daylight?
After creating your account, you can log into the Daylight app which is available as a mobile app from the Apple App Store or from Google Play.

During the COVID-19 public health emergency, Daylight is temporarily being made available as a treatment for insomnia disorder without a prescription. Daylight has not been cleared by the U.S. Food and Drug Administration (FDA) for the treatment of generalized anxiety disorder. Users are directed to not make any changes to their prescribed medication or other type of medical treatment without seeking professional medical advice.

1. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.
2. Miller, C. B., Carl, J. R., Henry, A. L., Baker, L. (2020). A health economic evaluation of Sleepio at a Fortune 500 company. Retrieved from: *This is a total estimate that is based on statistically significant and non-significant reductions in costs across categories; thus the exact figure would require confirmation in further research with a larger sample size.3. CDC – Data and Statistics – Sleep and Sleep Disorders. (2017). CDC.
4. Varkevisser, M., & Kerkhof, G. A. (2005). Chronic insomnia and performance in a 24‐h constant routine study. Journal of Sleep Research, 14(1), 49-59.
5. Shahly, V., Berglund, P. A., Coulouvrat, C., Fitzgerald, T., Hajak, G., Roth, T., … & Kessler, R. C. (2012). The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. Archives of general psychiatry, 69(10), 1054-1063.
6. Hertenstein, E., Feige, B., Gmeiner, T., Kienzler, C., Spiegelhalder, K., Johann, A., … & Baglioni, C. (2019). Insomnia as a predictor of mental disorders: a systematic review and meta-analysis. Sleep medicine reviews, 43, 96-105.
7. Sanofi-Aventis U.S. LLC. (2008). Ambien prescribing information: NDA 19908 S027 FDA approved labeling 4.23.08. Retrieved Jul 25, 2023, from
8. Sunovion Pharmaceuticals Inc. (2014). Lunesta prescribing information. Retrieved Jul 25, 2023, from

DOC-3043 Effective 07/2023